コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 horylation of its substrate Aurora kinase A (AurA).
2 early tonic motor features, and sensorimotor aura.
3 acute treatment of migraine with and without aura.
4 CSD), the putative mechanism of the migraine aura.
5 electrophysiologic event underlying migraine aura.
6 ura may decrease both headache frequency and aura.
7 re monogenic subtype of common migraine with aura.
8 ion (SD), the phenomenon underlying migraine aura.
9 ine (FHM) is a rare subtype of migraine with aura.
10 graine and in one patient with migraine with aura.
11 support a novel mechanism of activation for AurA.
12 is a key pathogenetic step in migraine with aura.
13 n 4 of 7 patients with otherwise intractable aura.
14 osphorylation is necessary for activation of AurA.
15 d risk of RAO compared with migraine without aura.
16 e phenotype in this variant of migraine with aura.
17 that underlie the headache of migraine with aura.
18 d in migraine attacks that begin with visual aura.
19 vascular unit in the development of migraine aura.
20 s cerebral emboli, stroke, and migraine with aura.
21 ree attacks over 3 months while experiencing aura.
22 eatment for some patients with migraine with aura.
23 lmodulin (CaM) binding to multiple motifs on AurA.
24 xtracardiac right-to-left shunts to migraine aura.
25 icantly higher than those with migraine with aura.
26 device for acute treatment of migraine with aura.
27 slow depolarization that underlies migraine aura.
28 ophobia from migraine with or without visual aura.
29 rment of noise exclusion in migraine without aura.
30 tween headaches in migraine with and without aura.
31 depolarization thought to underlie migraine aura.
32 (CSD) is likely the underlying phenomenon of aura.
33 re as a therapy for migraine with or without aura.
34 and efficacy in patients with versus without aura.
35 hallenging task of capturing patients during aura.
36 redominant sensory phenomenology of migraine aura.
37 n the treatment of migraine with and without aura.
38 extra-axial tissues in migraine with visual aura.
39 l field testing in migraine patients without aura.
40 ed as the cellular correlate of the migraine aura.
41 g the occipital lobe in migraine with visual auras.
42 gned patients with migraine with and without aura (1:1:1:1 ratio) to oral lasmiditan 200 mg, 100 mg,
44 tesla in 131 patients with migraine (38 with aura; 30.8 +/- 9 years old; 109 women; monthly attack fr
45 re consumed, with Turkey Vultures (Cathartes aura, 47%) and American Alligators (Alligator mississipp
50 fold and activating its associated Aurora-A (AurA), a kinase crucially required for primary cilia dis
52 target Thr-295 of AurA to prevent premature AurA activation during interphase and that phosphorylate
54 tein for Xklp2 (TPX2), a known MT-localizing AurA activator, is an AurA cofactor in centrosome-driven
55 In contrast with previously characterized AurA activators, NPM does not trigger autophosphorylatio
56 no history of migraine, active migraine with aura, active migraine without aura, and past history of
62 %) did not (2177 [7.8%] had migraine without aura and 24 246 [87.0%] had no migraine in the year prio
63 s), among whom 1435 (5.2%) had migraine with aura and 26 423 (94.8%) did not (2177 [7.8%] had migrain
64 al noise-exclusion deficits in migraine with aura and a minor impairment of noise exclusion in migrai
67 ts suggest an essential combined function of AurA and AurB in chromosome segregation and anaphase MT
69 common migraine phenotypes because of shared aura and headache features, trigger factors, and underly
70 en-labeled pilot study of patients, reducing aura and headache symptoms in 4 of 7 patients with other
72 a new context for evaluating the function of AurA and its inhibitors in normal and cancerous cells.
73 stic types of migraine, termed migraine with aura and migraine without aura, from the International H
75 results suggest a novel relationship between AurA and protein phosphatases during progression through
76 l RNFL thinning in migraine patients without aura and pulsative choroidal blood flow may not be affec
79 o explain the sensory nature of the migraine aura and reveal that sensory cortices are vulnerable in
81 n PFO prevalence in those with migraine with aura and those without (26.8% versus 26.1%; odds ratio 1
82 of intracranial origin such as migraine with aura and why this therapeutic approach may not be effect
84 d surface area abnormalities were related to aura and WMHs (P < .01) but not to disease duration and
85 providing a novel mechanism in migraine with aura and, by extension, the other neurological disorders
87 quire the serine/threonine kinase, Aurora A (AurA), and the centrosomal protein of 192 kDa (Cep192)/s
89 electrophysiological surrogate for migraine aura, and develop severe and prolonged motor deficits af
90 sion, the experimental correlate of migraine aura, and further evaluated the response of spontaneous
91 ng depression, the experimental correlate of aura, and inhibited trigeminal activation in in vivo mig
94 Ten migraine with aura, ten migraine without aura, and ten age-matched headache-free subjects partici
95 e initiation and propagation of the migraine aura, and the visual percept that is produces, remain un
96 atrial fibrillation; migraine headache with aura; and the epidemiology of types of stroke, such as a
98 cohort suggest that women with migraine with aura are at increased risk of experiencing TIA or ischem
101 cantly thinner in the migraine patients with aura as compared with both the migraine patients without
103 thermore, an AurA(KS degrees , ACP degrees )-AurA(AT(0)) heterodimer proved to be nonfunctional, wher
106 rst through lower nasal field (69-77% of all auras) before travelling to upper and temporal fields, o
109 nhibition of kinetochore-associated pools of AurA blocks phosphorylation of microtubule-kinetochore c
115 (CSD)--an event believed to underlie visual aura--can give rise to activation of nociceptors that in
116 type 1 (FHM1) is a subtype of migraine with aura caused by a gain-of-function mutation in the pore-f
118 tion of Cep192 or specific interference with AurA-Cep192 binding did not prevent AurA oligomerization
121 Familial history of stroke, migraine with aura, circulating antiphospholipid antibodies, discontin
122 depression, the neural correlate of migraine aura, closes the paravascular space and impairs glymphat
123 a known MT-localizing AurA activator, is an AurA cofactor in centrosome-driven spindle assembly.
125 gnificantly more common in the migraine with aura compared to control group (73% vs. 51%, p = 0.02),
127 e distribution of other concomitant types of aura, demographic, clinical or neurosurgical variables.
130 and its subtypes (presence or absence of an aura) differs between patients whose IS was due to CEAD
131 la chrysaetos, and turkey vulture, Cathartes aura, during autumn migration across eastern North Ameri
132 risons (migraineurs vs control subjects, the aura effect, the effect of white matter hyperintensities
134 cessive maternal-effect mutation in the gene aura exhibit defects including reduced cortical integrit
135 ts were adults with migraine with or without aura experiencing 2 to 8 migraine attacks per month.
138 rly hypermotor signs, early recovery, and no aura from posterior insula features of early dystonia, e
139 rmed migraine with aura and migraine without aura, from the International Headache Genetics Consortiu
140 arcs, and drug inhibition is consistent with aura function promoting F-actin polymerization and/or st
141 ever, we and others have recently identified AurA functions as diverse as control of ciliary resorpti
143 orty-five patients who had migraines without aura (Group 1), 45 patients who had migraines with aura
144 Group 1), 45 patients who had migraines with aura (Group 2), and 30 healthy participants (control gro
145 at least 45 years, women with migraine with aura had a higher adjusted incidence rate of CVD compare
147 or stroke, women who reported migraine with aura had adjusted relative risk (95% confidence interval
152 ion of aPKC, AurA, or a downstream target of AurA, HDAC6, restores ciliogenesis in ceramide-depleted
154 20 patients had comorbid migraine, five with aura; (ii) to identify systematically additional visual
160 d drawings of his visual percept of migraine aura in real time during more than 1000 attacks of migra
162 eractivation of the mitotic kinase Aurora-A (AurA) in cancer is associated with genomic instability.
163 d a conditional deletion of Aurora A kinase (AurA) in Cdk1 analogue-sensitive DT40 cells to analyze A
164 signed adults with migraine, with or without aura, in a 1:1:1 ratio to receive an initial dose of pla
167 epression (CSD), an animal model of migraine aura, induces a rapid and nearly complete closure of the
168 y of Polo-like kinase 1 (Plk1) and Aurora A (AurA) inhibitors attenuates kinase activity, produces sp
169 that there can be multiple distinct sites of aura initiation in a given individual and suggest that t
171 modelling, we map two primary regions of CaM-AurA interaction to unfolded sequences in the AurA N- an
176 ning approach indicates that the mutation in aura is associated with a truncation of Mid1 interacting
177 d risk of all types of RAO and migraine with aura is associated with increased risk of RAO compared w
180 nal analyses revealed that the N-terminus of AurA is not involved in the iteration process, ruling ou
189 e electrophysiological substrate of migraine aura, is enhanced in mice expressing a vascular Notch 3
190 ne type 1, a monogenic migraine variant with aura, is linked to gain-of-function mutations in the CAC
191 ation indeed influenced this timing, because AurA isoforms retaining an intact Thr-295 residue furthe
192 risk of stroke in people with migraine with aura, it is important to identify and modify any vascula
193 emonstrate that NPM is a strong activator of AurA kinase activity at the centrosome and support a nov
195 losteric pocket of the oncoprotein Aurora A (AurA) kinase, thereby offering the potential for more sp
199 severe headaches that can be preceded by an aura likely caused by cortical spreading depression (SD)
200 fails to complement the originally isolated aura maternal-effect mutation, confirming gene assignmen
202 e contraceptive use in MRM and migraine with aura may decrease both headache frequency and aura.
203 translatable to humans, a subset of migraine auras may belong to a spectrum of hypoperfusion disorder
206 ational Aeronautics and Space Administration Aura Microwave Limb Sounder (MLS) to infer an expression
207 ur studies indicate that maternally provided aura (mid1ip1l) acts during the reorganization of the cy
208 These and other observations suggested that AurA might be involved in pathological conditions, such
212 ntemporaneous measurements of ozone from the Aura-MLS satellite, although the short time period makes
213 and migraine with (MA) and migraine without aura (MO) were identified by a screener, which we valida
215 atory system (DPMS) between migraine without aura (MwoA) patients and healthy controls (HC), and 2) i
217 8-10.00]; P < .001), either migraine without aura (n = 142; 73.9% vs 26.5%; OR, 7.01 [95% CI, 4.43-11
218 CI, 4.43-11.09]; P < .001), or migraine with aura (n = 66; 69.7% vs 26.5%; OR, 5.73 [95% CI, 3.07-10.
219 eferential for migraine with aura or without aura, nor were any associations specific for migraine fe
223 ep, the early and acute psychotic state, the aura of temporal lobe epilepsy and hallucinogenic drug s
226 nce with AurA-Cep192 binding did not prevent AurA oligomerization on MTs but abrogated AurA recruitme
231 ith impaired awareness in those experiencing auras only, those with no seizures and those with contin
238 ociations was preferential for migraine with aura or without aura, nor were any associations specific
242 Aqua Atmospheric Infrared Sounder (AIRS) CO, Aura Ozone Monitoring Instrument (OMI) aerosol index, an
244 In migraine, both with aura and without aura, patients' choroid thinning should be considered wh
245 hosphatase would be insufficient to restrict AurA phosphorylation and regulate CDK1 activation, where
246 ous diagnoses, including persistent migraine aura, post-hallucinogen flashback, or psychogenic disord
247 criteria for migraine with aura, with visual aura preceding at least 30% of migraines followed by mod
249 ease in the incidence rate for migraine with aura ranged from 1.01 additional cases per 1000 person-y
250 terize and quantify a large number of visual auras recorded by a single individual over nearly two de
251 nt AurA oligomerization on MTs but abrogated AurA recruitment to centrosomes and its activation by ei
255 ional Aeronautics and Space Administration's Aura satellite suggest an approximately 7-10% decrease i
256 e visual disturbance (36%), whereas migraine aura (seven patients) and consumption of illicit drugs (
257 levels, with performance of migraineurs with aura significantly poorer (P < 0.05) than that of contro
258 al seizures with no impairment of awareness (auras, simple partial seizures) continue, if there is a
260 iated with haemorrhagic stroke, the migraine aura status has a small influence on this relationship.
261 ients had been enrolled at one centre in the AURA study, had shown resistance to a previous EGFR TKI,
262 of circle of Willis variants, migraine with aura subjects had a higher burden of variants than contr
263 le of Willis is more common in migraine with aura subjects than controls, and is associated with alte
264 on between the multifaceted phenomenology of aura symptoms and the effects of CSD on the brain has no
265 atients were studied during various forms of aura symptoms induced by hypoxia, sham hypoxia, or physi
266 ATION: These findings suggest that different aura symptoms reflect different types of cerebral dysfun
272 on during interphase and that phosphorylated AurA(Thr-295) acts as a competitor substrate with a CDK1
273 ivity other than PP1 continuously suppresses AurA(Thr-295) phosphorylation during the early embryonic
276 nsitive to OA caused an abnormal increase in AurA(Thr-295) phosphorylation late during interphase tha
278 The absolute contribution of migraine with aura to CVD incidence in relation to other CVD risk fact
279 ep192, through a direct interaction, targets AurA to mitotic centrosomes where the locally accumulati
280 pose that two phosphatases target Thr-295 of AurA to prevent premature AurA activation during interph
281 CSD), the proposed mechanism of the migraine aura, to shape the cortical activity that underlies sens
282 ten begin with warning signs (prodromes) and aura (transient focal neurological symptoms) whose origi
283 our major phenotypes (migraine with multiple auras, transient focal neurological deficits without hea
284 atients who have migraines, with and without aura, using spectral optical coherence tomography (OCT).
285 nt of a trans-proteolytic activity assay for Aura virus capsid protease (AVCP) based on fluorescence
286 CI, 2.72-3.99) for women with migraine with aura vs 2.11 (95% CI, 1.98-2.24) for women with migraine
287 ed with migraine with aura, migraine without aura was independently associated with CEAD IS (OR, 1.74
288 incidence rate for women with migraine with aura was significantly higher than the adjusted incidenc
289 on documenting the shape and location of the aura wavefront or scotoma in the visual field at one min
291 d from trees, and turkey vultures (Cathartes aura) were the primary scavengers of arboreal carrion, s
292 ypertension and migraine, especially without aura, were confirmed as risk factors for CeAD, in additi
293 ts activation of HDAC6 by cytosolic aPKC and AurA, which promotes acetylation of tubulin in primary c
294 e in patients with episodic migraine without aura who habitually experienced premonitory symptoms dur
295 treating cells exclusively expressing the as-AurA with 1-Na-PP1, we discovered that Aurora A is requi
296 eet international criteria for migraine with aura, with visual aura preceding at least 30% of migrain
300 ne is strongly associated with migraine with aura, young age, female sex, use of oral contraceptives